Court Finds That Qui Tam Relator Cannot Enforce 340B Program Statute
Sidley – A recent decision from the Central District of California held that a qui tam relator cannot bring a False Claims Act case against pharmaceutical manufacturers to enforce the 340B Drug Pricing Program’s statutory requirements.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.